$SLDB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Solid Biosciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Solid Biosciences Inc.. Get notifications about new insider transactions in Solid Biosciences Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Option Exercise | A | 5.23 | 25,000 | 130,750 | 25,000 | |
| Apr 05 2021 | SLDB | Solid Biosciences ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 5.53 | 663,720 | 3,670,372 | 11,580,287 | 10.9 M to 11.6 M (+6.08 %) |
| Apr 05 2021 | SLDB | Solid Biosciences ... | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 5.53 | 787,586 | 4,355,351 | 787,586 | 0 to 787.6 K |
| Mar 23 2021 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 5.75 | 2,608,695 | 14,999,996 | 13,412,552 | 10.8 M to 13.4 M (+24.15 %) |
| Mar 15 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Sell | S | 8.85 | 11,699 | 103,488 | 275,602 | 287.3 K to 275.6 K (-4.07 %) |
| Mar 15 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Sell | S | 8.84 | 11,699 | 103,459 | 287,301 | 299 K to 287.3 K (-3.91 %) |
| Mar 15 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Operating Off ... | Sell | S | 8.84 | 11,699 | 103,452 | 268,774 | 280.5 K to 268.8 K (-4.17 %) |
| Mar 15 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Operating Off ... | Sell | S | 8.84 | 11,699 | 103,468 | 280,473 | 292.2 K to 280.5 K (-4.00 %) |
| Mar 04 2021 | SLDB | Solid Biosciences ... | Keresty Georgia | Director | Option Exercise | A | 10.72 | 40,000 | 428,800 | 40,000 | |
| Mar 04 2021 | SLDB | Solid Biosciences ... | Kahn Clare | Director | Option Exercise | A | 10.72 | 40,000 | 428,800 | 40,000 | |
| Mar 04 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Operating Off ... | Option Exercise | A | 10.72 | 15,000 | 160,800 | 15,000 | |
| Mar 03 2021 | SLDB | Solid Biosciences ... | Brennan Erin Powers | Chief Legal Officer ... | Option Exercise | A | 8.52 | 325,000 | 2,769,000 | 325,000 | |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Option Exercise | M | 0.00 | 11,500 | 0 | 0 | |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Sell | S | 6.14 | 3,443 | 21,145 | 292,172 | 295.6 K to 292.2 K (-1.16 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Buy | M | 0.00 | 11,500 | 0 | 295,615 | 284.1 K to 295.6 K (+4.05 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Option Exercise | M | 0.00 | 11,500 | 0 | 0 | |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Sell | S | 6.14 | 3,473 | 21,327 | 335,636 | 339.1 K to 335.6 K (-1.02 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Buy | M | 0.00 | 11,500 | 0 | 339,109 | 327.6 K to 339.1 K (+3.51 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,500 | 0 | 0 | |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Sell | S | 6.14 | 3,459 | 21,238 | 299,000 | 302.5 K to 299 K (-1.14 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Buy | M | 0.00 | 11,500 | 0 | 302,459 | 291 K to 302.5 K (+3.95 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | M | 0.00 | 35,500 | 0 | 0 | |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Sell | S | 6.14 | 10,713 | 65,776 | 1,199,821 | 1.2 M to 1.2 M (-0.88 %) |
| Jan 29 2021 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Buy | M | 0.00 | 35,500 | 0 | 1,210,534 | 1.2 M to 1.2 M (+3.02 %) |
| Jan 27 2021 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Option Exercise | A | 6.80 | 175,000 | 1,190,000 | 175,000 | |
| Jan 27 2021 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 6.80 | 8,100 | 55,080 | 8,100 | |
| Jan 27 2021 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 6.80 | 438,000 | 2,978,400 | 438,000 | |
| Jan 27 2021 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | A | 6.80 | 175,000 | 1,190,000 | 175,000 | |
| Jan 06 2021 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 7.84 | 389,000 | 3,049,760 | 389,000 | |
| Dec 15 2020 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Grant | A | 3.70 | 4,054,054 | 15,000,000 | 10,803,857 | 6.7 M to 10.8 M (+60.06 %) |
| Dec 14 2020 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Grant | A | 3.70 | 4,938,282 | 18,271,643 | 8,709,882 | 3.8 M to 8.7 M (+130.93 %) |
| Dec 14 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Grant | A | 3.70 | 270,270 | 999,999 | 270,270 | 0 to 270.3 K |
| Dec 14 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Grant | A | 3.70 | 27,027 | 100,000 | 1,175,034 | 1.1 M to 1.2 M (+2.35 %) |
| Dec 14 2020 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Grant | A | 3.70 | 432,432 | 1,599,998 | 3,933,429 | 3.5 M to 3.9 M (+12.35 %) |
| Dec 11 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 3.70 | 3,189,189 | 11,799,999 | 7,060,353 | 3.9 M to 7.1 M (+82.38 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Option Exercise | M | 0.00 | 11,500 | 0 | 11,500 | |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Sell | S | 2.42 | 4,041 | 9,776 | 284,115 | 288.2 K to 284.1 K (-1.40 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Buy | M | 0.00 | 11,500 | 0 | 288,156 | 276.7 K to 288.2 K (+4.16 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,500 | 0 | 11,500 | |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Sell | S | 2.42 | 3,591 | 8,689 | 290,959 | 294.6 K to 291 K (-1.22 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Buy | M | 0.00 | 11,500 | 0 | 294,550 | 283.1 K to 294.6 K (+4.06 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Option Exercise | M | 0.00 | 11,500 | 0 | 11,500 | |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Sell | S | 2.42 | 3,591 | 8,687 | 327,609 | 331.2 K to 327.6 K (-1.08 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Buy | M | 0.00 | 11,500 | 0 | 331,200 | 319.7 K to 331.2 K (+3.60 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Option Exercise | M | 0.00 | 16,000 | 0 | 16,000 | |
| Jul 29 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Sell | S | 2.42 | 5,141 | 12,438 | 160,859 | 166 K to 160.9 K (-3.10 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Buy | M | 0.00 | 16,000 | 0 | 166,000 | 150 K to 166 K (+10.67 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | M | 0.00 | 35,500 | 0 | 35,500 | |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Sell | S | 2.42 | 11,124 | 26,910 | 1,148,007 | 1.2 M to 1.1 M (-0.96 %) |
| Jul 29 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Buy | M | 0.00 | 35,500 | 0 | 1,159,131 | 1.1 M to 1.2 M (+3.16 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Stone Adam Leo | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Grant | A | 0.00 | 75,000 | 0 | 319,700 | 244.7 K to 319.7 K (+30.65 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Grant | A | 0.00 | 75,000 | 0 | 276,656 | 201.7 K to 276.7 K (+37.19 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Grant | A | 0.00 | 75,000 | 0 | 283,050 | 208.1 K to 283.1 K (+36.05 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Grant | A | 0.00 | 75,000 | 0 | 150,000 | 75 K to 150 K (+100.00 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 3.03 | 200,000 | 606,000 | 200,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Sullivan Lynne Marie | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Huffines Robert Luther | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Apr 16 2020 | SLDB | Solid Biosciences ... | SMITH IAN F | Director | Option Exercise | A | 2.49 | 40,000 | 99,600 | 40,000 | |
| Mar 13 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Grant | A | 0.00 | 75,000 | 0 | 201,656 | 126.7 K to 201.7 K (+59.22 %) |
| Mar 13 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Grant | A | 0.00 | 75,000 | 0 | 201,656 | 126.7 K to 201.7 K (+59.22 %) |
| Mar 13 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Grant | A | 0.00 | 75,000 | 0 | 244,700 | 169.7 K to 244.7 K (+44.20 %) |
| Mar 13 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
| Feb 14 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | M | 0.00 | 800 | 0 | 2,430 | |
| Feb 14 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Payment of Exercise | F | 3.15 | 293 | 923 | 2,937 | 3.2 K to 2.9 K (-9.07 %) |
| Feb 14 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Buy | M | 0.00 | 800 | 0 | 3,230 | 2.4 K to 3.2 K (+32.92 %) |
| Feb 12 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Grant | A | 0.00 | 2,430 | 0 | 2,430 | 0 to 2.4 K |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | CFO, Treasurer & As ... | Option Exercise | A | 3.47 | 47,000 | 163,090 | 47,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | Chief Technology Of ... | Option Exercise | A | 3.47 | 47,000 | 163,090 | 47,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | A | 3.47 | 47,000 | 163,090 | 47,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Option Exercise | A | 0.00 | 32,000 | 0 | 32,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | Chief Legal Officer | Option Exercise | A | 3.47 | 65,000 | 225,550 | 65,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 0.00 | 71,000 | 0 | 71,000 | |
| Jan 29 2020 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 3.47 | 142,000 | 492,740 | 142,000 | |
| Aug 14 2019 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 0.00 | 1,600 | 0 | 1,600 | |
| Jul 30 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 4.65 | 1,881,720 | 8,749,998 | 3,871,164 | 2 M to 3.9 M (+94.59 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 4.65 | 2,822,581 | 13,125,002 | 6,749,803 | 3.9 M to 6.7 M (+71.87 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Grant | A | 4.65 | 1,881,720 | 8,749,998 | 4,571,164 | 2.7 M to 4.6 M (+69.97 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Grant | A | 4.65 | 32,258 | 150,000 | 34,258 | 2 K to 34.3 K (+1,612.90 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Grant | A | 4.65 | 21,505 | 99,998 | 133,050 | 111.5 K to 133.1 K (+19.28 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Grant | A | 4.65 | 21,505 | 99,998 | 1,123,631 | 1.1 M to 1.1 M (+1.95 %) |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Grant | A | 4.65 | 53,763 | 249,998 | 53,763 | 0 to 53.8 K |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Grant | A | 4.65 | 677,419 | 3,149,998 | 3,500,997 | 2.8 M to 3.5 M (+23.99 %) |
| Jul 12 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Gift | G | 0.00 | 562,715 | 0 | 2,823,578 | 3.4 M to 2.8 M (-16.62 %) |
| Jun 17 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 17 2019 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 17 2019 | SLDB | Solid Biosciences ... | Stone Adam Leo | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 14 2019 | SLDB | Solid Biosciences ... | Zarur Juan Andrey | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 14 2019 | SLDB | Solid Biosciences ... | Sullivan Lynne Marie | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 14 2019 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 14 2019 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Jun 14 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| May 10 2019 | SLDB | Solid Biosciences ... | Zarur Juan Andrey | Director | Sell | S | 10.00 | 8,000 | 80,039 | 10,189 | 18.2 K to 10.2 K (-43.98 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 9.53 | 60,000 | 571,800 | 3,473,272 | 3.5 M to 3.5 M (-1.70 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 9.53 | 60,000 | 571,800 | 3,473,272 | 3.5 M to 3.5 M (-1.70 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 9.60 | 115,000 | 1,104,000 | 3,533,272 | 3.6 M to 3.5 M (-3.15 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 9.60 | 115,000 | 1,104,000 | 3,533,272 | 3.6 M to 3.5 M (-3.15 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 10.08 | 275,000 | 2,772,000 | 3,648,272 | 3.9 M to 3.6 M (-7.01 %) |
| Mar 28 2019 | SLDB | Solid Biosciences ... | Boxer Capital, LLC | 10% Owner | Sell | S | 10.08 | 275,000 | 2,772,000 | 3,648,272 | 3.9 M to 3.6 M (-7.01 %) |
| Feb 21 2019 | SLDB | Solid Biosciences ... | HERSCHA LYNETTE | See Remark | Option Exercise | A | 8.20 | 50,000 | 410,000 | 50,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Option Exercise | A | 22.93 | 60,000 | 1,375,800 | 60,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Option Exercise | A | 22.93 | 155,000 | 3,554,150 | 155,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Morris Carl Ashley | Chief Scientific Of ... | Option Exercise | A | 22.93 | 60,000 | 1,375,800 | 60,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Ziolkowski Jennifer Lynn | Chief Financial Off ... | Option Exercise | A | 22.93 | 60,000 | 1,375,800 | 60,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Option Exercise | A | 22.93 | 60,000 | 1,375,800 | 60,000 | |
| Jan 25 2019 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | See Remarks | Option Exercise | A | 22.93 | 60,000 | 1,375,800 | 60,000 | |
| Jan 16 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Sell | S | 32.20 | 3,300 | 106,258 | 3,386,293 | 3.4 M to 3.4 M (-0.10 %) |
| Jan 16 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Sell | S | 31.60 | 1,700 | 53,724 | 3,389,593 | 3.4 M to 3.4 M (-0.05 %) |
| Jan 08 2019 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Sell | S | 30.08 | 5,000 | 150,407 | 3,391,293 | 3.4 M to 3.4 M (-0.15 %) |
| Jan 08 2019 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 30.07 | 9,000 | 270,619 | 158,046 | 167 K to 158 K (-5.39 %) |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Stone Adam Leo | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Sullivan Lynne Marie | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Zarur Juan Andrey | Director | Option Exercise | A | 23.58 | 10,000 | 235,800 | 10,000 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Freed Martin I | Director | Option Exercise | A | 23.58 | 16,331 | 385,085 | 16,331 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 23.58 | 17,240 | 406,519 | 17,240 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Arnold Matthew Bennett | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Huffines Robert Luther | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 32.38 | 300 | 9,715 | 167,046 | 167.3 K to 167 K (-0.18 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 31.44 | 5,693 | 178,996 | 167,346 | 173 K to 167.3 K (-3.29 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 30.20 | 3,007 | 90,823 | 173,039 | 176 K to 173 K (-1.71 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Sell | S | 32.24 | 1,370 | 44,174 | 228,092 | 229.5 K to 228.1 K (-0.60 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Sell | S | 31.41 | 31,426 | 987,147 | 229,462 | 260.9 K to 229.5 K (-12.05 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Sell | S | 30.21 | 6,154 | 185,900 | 260,888 | 267 K to 260.9 K (-2.30 %) |
| Dec 04 2018 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Sell | S | 29.94 | 1,200 | 35,924 | 267,042 | 268.2 K to 267 K (-0.45 %) |
| Nov 20 2018 | SLDB | Solid Biosciences ... | Quiroz Jorge Armando | Chief Medical Offic ... | Sell | S | 34.90 | 100 | 3,490 | 268,242 | 268.3 K to 268.2 K (-0.04 %) |
| Nov 20 2018 | SLDB | Solid Biosciences ... | Zarur Juan Andrey | Director | Sell | S | 35.00 | 100 | 3,500 | 691,105 | 691.2 K to 691.1 K (-0.01 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Sell | S | 31.06 | 19,100 | 593,319 | 1,102,126 | 1.1 M to 1.1 M (-1.70 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Ganot Ilan | CEO & President | Sell | S | 30.70 | 30,900 | 948,615 | 1,121,226 | 1.2 M to 1.1 M (-2.68 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | See Remarks | Sell | S | 31.10 | 8,542 | 265,625 | 126,656 | 135.2 K to 126.7 K (-6.32 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Schneider Joel Solomon Zev | See Remarks | Sell | S | 30.68 | 13,448 | 412,555 | 132,958 | 146.4 K to 133 K (-9.19 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 31.08 | 4,300 | 133,632 | 171,746 | 176 K to 171.7 K (-2.44 %) |
| Nov 19 2018 | SLDB | Solid Biosciences ... | Amorrortu Pedro Alvaro | Chief Operating Off ... | Sell | S | 30.61 | 4,700 | 143,847 | 176,046 | 180.7 K to 176 K (-2.60 %) |
| Sep 13 2018 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 50.65 | 2,760 | 139,794 | 2,760 | |
| Aug 28 2018 | SLDB | Solid Biosciences ... | Hayeem Gilad David | 10% Owner | Gift | G | 0.00 | 35,653 | 0 | 1,948,991 | 2 M to 1.9 M (-1.80 %) |
| Jul 27 2018 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 | |
| Jul 27 2018 | SLDB | Solid Biosciences ... | Stone Adam Leo | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 |